Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

A new pill is helping people with Type 2 diabetes lose weight and lower blood sugar in a phase-three clinical trial.

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

Ottawa, April 25, 2025 (GLOBE NEWSWIRE) -- According to Statifacts, the global insulin delivery pens market size was exhibited at USD 26,412 million in 2024 and is projected to grow USD 58,086 ...

Eli Lilly's Phase 3 study highlights the effectiveness of Orforglipron ... According to the Cleveland Clinic, these medications manage blood sugar levels by triggering insulin release from the ...

Notably, GLP-1 drugs help regulate blood sugar, insulin levels, and appetite, mainly treating type 2 diabetes and, more recently, obesity. Eli Lilly currently markets two GLP-1 receptor agonist ...